← All stocks

ProQR Therapeutics N.V.

PRQR Net buying

CIK 0001612940 #3479 in the set updated 17 Sep 2026

Bought (120 mo)

$1.34M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$1.34M

+$1.34M against sales at will

By person

2 insiders · 5 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

de Boer Daniel Anton

Chief Executive Officer

$853.46K (3)

—

+$853.46K

500,000

0.4746%

$884.90K

—

Filius Bart

Director

$488.93K (2)

—

+$488.93K

300,000

0.2847%

$530.94K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 6

Amendments (4/A) skipped 1

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 3 Jun 2026